What it means
MOTS-c is one of a handful of short peptides made from instructions in mitochondrial DNA rather than the cell nucleus. Mouse studies suggested it may affect how muscles use sugar and how the body responds to diet and exercise. That research is early.
The FDA lists MOTS-c among bulk substances nominated for compounding that may raise significant safety concerns. The agency said it had no human exposure data for any route of use and lacked important safety information. MOTS-c was among the peptides discussed at an FDA advisory committee meeting in July 2026; check FDA pages for any later decision.
There are no published trials showing that MOTS-c causes weight loss in people. It is not FDA-approved, and products sold online are unregulated.
Sunny Weigh does not give dosing or buying information for unapproved substances.
Why it matters
Interesting mouse research is a long way from a proven medicine, and MOTS-c has not made that journey.
Related terms
Sources
Clinician review pending. Drafted from primary sources and waiting for sign-off by a licensed clinician (MD, DO or PharmD) before launch. Every number is checked against its source. Drug facts are re-checked quarterly, prices monthly and whenever a label changes. How we review · Report an error